Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
6.74
-0.48 (-6.65%)
At close: Aug 7, 2025, 4:00 PM
6.70
-0.04 (-0.59%)
Pre-market: Aug 8, 2025, 7:00 AM EDT

Indaptus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
7.528.118.768.595.210.94
Upgrade
Research & Development
8.477.257.626.322.522.66
Upgrade
Operating Expenses
1615.3716.3814.917.733.6
Upgrade
Operating Income
-16-15.37-16.38-14.91-7.73-3.6
Upgrade
Other Non Operating Income (Expenses)
0.250.340.960.590.020.02
Upgrade
Pretax Income
-15.75-15.02-15.42-14.32-7.71-3.58
Upgrade
Net Income
-15.75-15.02-15.42-14.32-7.71-3.58
Upgrade
Net Income to Common
-15.75-15.02-15.42-14.32-7.71-3.58
Upgrade
Shares Outstanding (Basic)
000000
Upgrade
Shares Outstanding (Diluted)
000000
Upgrade
Shares Change (YoY)
28.05%11.36%1.68%101.98%110.35%165.43%
Upgrade
EPS (Basic)
-40.94-44.96-51.41-48.54-52.78-51.61
Upgrade
EPS (Diluted)
-40.94-44.96-51.41-48.54-52.78-51.61
Upgrade
Free Cash Flow
-13.43-12.32-13.41-13.08-11.29-3.32
Upgrade
Free Cash Flow Per Share
-34.92-36.88-44.68-44.32-77.31-47.87
Upgrade
EBITDA
-15.99-15.37-16.38-14.91-7.73-3.6
Upgrade
D&A For EBITDA
000000
Upgrade
EBIT
-16-15.37-16.38-14.91-7.73-3.6
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q